SEC Form 4 · accession 0000899243-18-017743
Whitehawk Therapeutics, Inc. · WHWK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cheryl Cohen
Director
Period of report
Jun 20, 2018
Accepted (ET)
Jun 22, 2018 · 5:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001422142
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.00 | Jun 20, 2018 | A | 42,800 | A | — | Jun 20, 2028 | Common Stock | 42,800 | 42,800 | D |
Explanation of responses
- F1Options shall vest annually over three years from the Grant Date, subject to director's continued service on the Board at such time.